POSTPONED: The Leukemia & Lymphoma Society (LLS) Day with MassBio

Thursday, June 20 2013
3:30 pm – 6:00 pm

Location: MassBio, 300 Technology Square, 8th Floor, Cambridge, MA

** THIS EVENT HAS BEEN POSTPONED. STAY TUNED FOR A NEW DATE IN OCTOBER 2013**

 

 

Please join us on Thursday, June 20th, 2013 for a private meeting and reception with a select group of MassBio members and senior leaders from The Leukemia and Lymphoma Society’s Therapy Acceleration Program™ (TAP)

 

LLS’s TAP officers will host a discussion to present partnering strategies, and review current areas of potential funding to support critical unmet needs in the blood cancer space.  With an annual budget in excess $20M, LLS’s TAP is interested in building alliances with companies that have oncology, inflammation or similar assets with potential to change standard of care for blood cancer patients. The event will conclude with a networking reception.

This event will focus on LLS’s TAP’s interest in meeting with companies with late pre-clinical assets or programs in clinical development.

To request a one on one meeting, please contact Rakhshita Dhar at rakhshita.dhar@massbio.org or 617-674-5143. Space is limited.

AGENDA:

3:00 – 3:30 pm Arrival & Registration

3:30- 4:15 pm Plenary session: Overview of Leukemia Lymphoma society’s Therapeutic Acceleration Program 

  • Allison Formal, VP of Research and Business Development

4:15 – 4:45 pm Closing Remarks and Q&A

4:45 – 6:00 pm Networking Cocktail Reception 

This event, part of the MassBio Pharma Day Series, will provide a great opportunity to network with LLS’s TAP officers and learn how disease foundations have stepped into and taken a larger role in the funding ecosystem. Learn how they evaluate external research and approach licensing and partnerships as well as academic and VC relationships.

 

To register for the session and networking reception, please contact Rakhshita Dhar at MassBio at Rakhshita.Dhar@massbio.org or (617) 674-5143. Space is limited.

 

Share MassBio

 

BioProcess

EvaluatePharma 

MassBio